Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ·Healthcare·Biotechnology
$3.22
+1.58%
Mkt Cap $1.90B
Analyst Ratings
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$5.50
Range $5.50 – $5.50
Implied Upside
+71.1%
Consensus $5.50 vs current $3.22
NASDAQ·Healthcare·Biotechnology
$3.22
+1.58%
Mkt Cap $1.90B
Buy
2
Hold
1
Sell
0
Price Target (8 analysts)
$5.50
Range $5.50 – $5.50
+71.1%
Consensus $5.50 vs current $3.22